Update on sentinel lymph node biopsy for early-stage vulvar cancer
Abstract Two prospective, multicenter clinical trials have demonstrated the feasibility and reproducibility of sentinel lymph node (SLN) biopsy as part of the standard management of early-stage vulvar carcinoma. On the basis of the results of these trials, many gynecologic oncologists have incorpora...
Gespeichert in:
| Veröffentlicht in: | Gynecologic oncology 2015-08, Vol.138 (2), p.472-477 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 477 |
|---|---|
| container_issue | 2 |
| container_start_page | 472 |
| container_title | Gynecologic oncology |
| container_volume | 138 |
| creator | Slomovitz, Brian M Coleman, Robert L Oonk, Maaike H.M van der Zee, Ate Levenback, Charles |
| description | Abstract Two prospective, multicenter clinical trials have demonstrated the feasibility and reproducibility of sentinel lymph node (SLN) biopsy as part of the standard management of early-stage vulvar carcinoma. On the basis of the results of these trials, many gynecologic oncologists have incorporated SLN biopsy for vulvar cancer into their practice. Studies have further shown that SLN biopsy is associated with better quality of life than full lymphadenectomy, is more cost-effective than full lymphadenectomy, and improved pathologic evaluation. A large observational study is currently evaluating the outcomes of patients with early-stage vulvar cancer according to the results of their SLN biopsy and the approach to their care; this study may confirm that full inguinofemoral lymphadenectomy is no longer necessary in most patients with this disease. Here, we review the published data supporting SLN biopsy as part of the standard of care for women with early-stage vulvar cancer and discuss future considerations for the management of this disease. |
| doi_str_mv | 10.1016/j.ygyno.2015.05.017 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1701318401</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090825815300020</els_id><sourcerecordid>1701318401</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-331722b812671e053e335d7a9747fb2755ad865b873013b7644a9ae6a20ab5303</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi1ERZdtf0El5COXLGM7jpMDSFDxUakSh7Zny3FmWy9eO9jJSvn3eNnCgQvSaObyvvPxDCFXDDYMWPNut1kelxA3HJjcQAmmXpAVg05WTSu7l2QF0EHVctmek9c57wBAAOOvyDlvgHPJ1Yp8ehgHMyGNgWYMkwvoqV_24xMNcUDauzjmhW5jomiSX6o8mUekh9kfTKLWBIvpgpxtjc94-VzX5OHL5_vrb9Xt96831x9vK1u39VQJwRTnfct4oxiCFCiEHJTpVK22PVdSmqFtZN-qsqToVVPXpjPYGA6mlwLEmrw99R1T_DljnvTeZYvem4Bxzpqp4mNtXfKaiJPUpphzwq0ek9ubtGgG-ghP7_RvePoIT0MJporrzfOAud_j8Nfzh1YRvD8JsJx5cJh0tg4Lg8EltJMeovvPgA__-K13wVnjf-CCeRfnFApBzXTmGvTd8X_H97FyPgAH8QsxhZRO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1701318401</pqid></control><display><type>article</type><title>Update on sentinel lymph node biopsy for early-stage vulvar cancer</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Slomovitz, Brian M ; Coleman, Robert L ; Oonk, Maaike H.M ; van der Zee, Ate ; Levenback, Charles</creator><creatorcontrib>Slomovitz, Brian M ; Coleman, Robert L ; Oonk, Maaike H.M ; van der Zee, Ate ; Levenback, Charles</creatorcontrib><description>Abstract Two prospective, multicenter clinical trials have demonstrated the feasibility and reproducibility of sentinel lymph node (SLN) biopsy as part of the standard management of early-stage vulvar carcinoma. On the basis of the results of these trials, many gynecologic oncologists have incorporated SLN biopsy for vulvar cancer into their practice. Studies have further shown that SLN biopsy is associated with better quality of life than full lymphadenectomy, is more cost-effective than full lymphadenectomy, and improved pathologic evaluation. A large observational study is currently evaluating the outcomes of patients with early-stage vulvar cancer according to the results of their SLN biopsy and the approach to their care; this study may confirm that full inguinofemoral lymphadenectomy is no longer necessary in most patients with this disease. Here, we review the published data supporting SLN biopsy as part of the standard of care for women with early-stage vulvar cancer and discuss future considerations for the management of this disease.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1016/j.ygyno.2015.05.017</identifier><identifier>PMID: 26022527</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Female ; Hematology, Oncology and Palliative Medicine ; Humans ; Lymph Nodes - pathology ; Lymphatic Metastasis ; Lymphoscintigraphy ; Neoplasm Staging ; Obstetrics and Gynecology ; Sentinel lymph node biopsy ; Sentinel Lymph Node Biopsy - methods ; Ultrastaging ; Vulvar cancer ; Vulvar Neoplasms - pathology</subject><ispartof>Gynecologic oncology, 2015-08, Vol.138 (2), p.472-477</ispartof><rights>Elsevier Inc.</rights><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-331722b812671e053e335d7a9747fb2755ad865b873013b7644a9ae6a20ab5303</citedby><cites>FETCH-LOGICAL-c484t-331722b812671e053e335d7a9747fb2755ad865b873013b7644a9ae6a20ab5303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ygyno.2015.05.017$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27911,27912,45982</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26022527$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Slomovitz, Brian M</creatorcontrib><creatorcontrib>Coleman, Robert L</creatorcontrib><creatorcontrib>Oonk, Maaike H.M</creatorcontrib><creatorcontrib>van der Zee, Ate</creatorcontrib><creatorcontrib>Levenback, Charles</creatorcontrib><title>Update on sentinel lymph node biopsy for early-stage vulvar cancer</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>Abstract Two prospective, multicenter clinical trials have demonstrated the feasibility and reproducibility of sentinel lymph node (SLN) biopsy as part of the standard management of early-stage vulvar carcinoma. On the basis of the results of these trials, many gynecologic oncologists have incorporated SLN biopsy for vulvar cancer into their practice. Studies have further shown that SLN biopsy is associated with better quality of life than full lymphadenectomy, is more cost-effective than full lymphadenectomy, and improved pathologic evaluation. A large observational study is currently evaluating the outcomes of patients with early-stage vulvar cancer according to the results of their SLN biopsy and the approach to their care; this study may confirm that full inguinofemoral lymphadenectomy is no longer necessary in most patients with this disease. Here, we review the published data supporting SLN biopsy as part of the standard of care for women with early-stage vulvar cancer and discuss future considerations for the management of this disease.</description><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Lymph Nodes - pathology</subject><subject>Lymphatic Metastasis</subject><subject>Lymphoscintigraphy</subject><subject>Neoplasm Staging</subject><subject>Obstetrics and Gynecology</subject><subject>Sentinel lymph node biopsy</subject><subject>Sentinel Lymph Node Biopsy - methods</subject><subject>Ultrastaging</subject><subject>Vulvar cancer</subject><subject>Vulvar Neoplasms - pathology</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi1ERZdtf0El5COXLGM7jpMDSFDxUakSh7Zny3FmWy9eO9jJSvn3eNnCgQvSaObyvvPxDCFXDDYMWPNut1kelxA3HJjcQAmmXpAVg05WTSu7l2QF0EHVctmek9c57wBAAOOvyDlvgHPJ1Yp8ehgHMyGNgWYMkwvoqV_24xMNcUDauzjmhW5jomiSX6o8mUekh9kfTKLWBIvpgpxtjc94-VzX5OHL5_vrb9Xt96831x9vK1u39VQJwRTnfct4oxiCFCiEHJTpVK22PVdSmqFtZN-qsqToVVPXpjPYGA6mlwLEmrw99R1T_DljnvTeZYvem4Bxzpqp4mNtXfKaiJPUpphzwq0ek9ubtGgG-ghP7_RvePoIT0MJporrzfOAud_j8Nfzh1YRvD8JsJx5cJh0tg4Lg8EltJMeovvPgA__-K13wVnjf-CCeRfnFApBzXTmGvTd8X_H97FyPgAH8QsxhZRO</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Slomovitz, Brian M</creator><creator>Coleman, Robert L</creator><creator>Oonk, Maaike H.M</creator><creator>van der Zee, Ate</creator><creator>Levenback, Charles</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150801</creationdate><title>Update on sentinel lymph node biopsy for early-stage vulvar cancer</title><author>Slomovitz, Brian M ; Coleman, Robert L ; Oonk, Maaike H.M ; van der Zee, Ate ; Levenback, Charles</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-331722b812671e053e335d7a9747fb2755ad865b873013b7644a9ae6a20ab5303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Lymph Nodes - pathology</topic><topic>Lymphatic Metastasis</topic><topic>Lymphoscintigraphy</topic><topic>Neoplasm Staging</topic><topic>Obstetrics and Gynecology</topic><topic>Sentinel lymph node biopsy</topic><topic>Sentinel Lymph Node Biopsy - methods</topic><topic>Ultrastaging</topic><topic>Vulvar cancer</topic><topic>Vulvar Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Slomovitz, Brian M</creatorcontrib><creatorcontrib>Coleman, Robert L</creatorcontrib><creatorcontrib>Oonk, Maaike H.M</creatorcontrib><creatorcontrib>van der Zee, Ate</creatorcontrib><creatorcontrib>Levenback, Charles</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Slomovitz, Brian M</au><au>Coleman, Robert L</au><au>Oonk, Maaike H.M</au><au>van der Zee, Ate</au><au>Levenback, Charles</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Update on sentinel lymph node biopsy for early-stage vulvar cancer</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>2015-08-01</date><risdate>2015</risdate><volume>138</volume><issue>2</issue><spage>472</spage><epage>477</epage><pages>472-477</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><abstract>Abstract Two prospective, multicenter clinical trials have demonstrated the feasibility and reproducibility of sentinel lymph node (SLN) biopsy as part of the standard management of early-stage vulvar carcinoma. On the basis of the results of these trials, many gynecologic oncologists have incorporated SLN biopsy for vulvar cancer into their practice. Studies have further shown that SLN biopsy is associated with better quality of life than full lymphadenectomy, is more cost-effective than full lymphadenectomy, and improved pathologic evaluation. A large observational study is currently evaluating the outcomes of patients with early-stage vulvar cancer according to the results of their SLN biopsy and the approach to their care; this study may confirm that full inguinofemoral lymphadenectomy is no longer necessary in most patients with this disease. Here, we review the published data supporting SLN biopsy as part of the standard of care for women with early-stage vulvar cancer and discuss future considerations for the management of this disease.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26022527</pmid><doi>10.1016/j.ygyno.2015.05.017</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0090-8258 |
| ispartof | Gynecologic oncology, 2015-08, Vol.138 (2), p.472-477 |
| issn | 0090-8258 1095-6859 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1701318401 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Female Hematology, Oncology and Palliative Medicine Humans Lymph Nodes - pathology Lymphatic Metastasis Lymphoscintigraphy Neoplasm Staging Obstetrics and Gynecology Sentinel lymph node biopsy Sentinel Lymph Node Biopsy - methods Ultrastaging Vulvar cancer Vulvar Neoplasms - pathology |
| title | Update on sentinel lymph node biopsy for early-stage vulvar cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T23%3A09%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Update%20on%20sentinel%20lymph%20node%20biopsy%20for%20early-stage%20vulvar%20cancer&rft.jtitle=Gynecologic%20oncology&rft.au=Slomovitz,%20Brian%20M&rft.date=2015-08-01&rft.volume=138&rft.issue=2&rft.spage=472&rft.epage=477&rft.pages=472-477&rft.issn=0090-8258&rft.eissn=1095-6859&rft_id=info:doi/10.1016/j.ygyno.2015.05.017&rft_dat=%3Cproquest_cross%3E1701318401%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1701318401&rft_id=info:pmid/26022527&rft_els_id=S0090825815300020&rfr_iscdi=true |